Increasing Batch Size and Reducing Cycle Times for a Biologic

See how smarter filling saved a biologic from a double-digit reject rate.  A small amount of liquid left on the vial wall can mean a costly reject, especially when a high-value API is on the line. For one client's high-value biologic, that meant reject rates reaching...

Find out how engineering-led cycle development bridged the gap from benchtop to validated-scale up. What works on a benchtop doesn't always survive the jump to a large-scale lyophilizer. See how JHS engineers identified the root cause of a failed PPQ validation run...

Unplanned equipment failures can lead to costly batch loss and production downtime—especially in biologics manufacturing. In this case study, learn how JHS uses AI-enabled predictive maintenance to stay ahead of risk: Monitor critical equipment like WFI pumps and AHUs...